Palomino Laboratories Inc. income statement PALX

It recorded a net loss of $3.2 million. Diluted earnings per share were -$0.47.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line
FY 2026
Jun 30, 2026
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
Selling, general and administrative
4
+1283.2%
3
+44042.3%
0
-92.7%
0
Operating income
-5
-3
-44042.3%
-0
—
Net income
-5
-878.7%
-3
-19428.3%
-0
+80.7%
-0
Basic EPS
-0.33
+85.4%
-0.47
-4181.8%
-0.01
+35.3%
-0.02
Diluted EPS
-0.33
+85.4%
-0.47
-4181.8%
-0.01
+35.3%
-0.02
Weighted average shares, basic
15
+6607.6%
7
+340.5%
2
-69.5%
5
Weighted average shares, diluted
15
+6607.6%
7
+340.5%
2
-69.5%
5
Other measures
Interest coverage
—
—
-1.06x
—
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

Company profile

Industry
Semiconductors & Related Devices (SIC 3674)
Listed as
PALX (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Goleta, CA
SEC filer status
, Emerging growth company
SEC CIK
1938569
Former names
Unite Acquisition 3 Corp. (until Aug 29, 2025)

Other Semiconductors & Related Devices companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.